Exabis Library
Welcome to the e-CCO Library!
P659 The impact of total colectomy on the course of extraintestinal manifestations in Swiss IBD cohort study patients
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P659: Colonoscopic screening of symptomatic patients suggests an emerging inflammatory bowel disease (IBD) in urban and rural south India
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P659: Continuing or stopping 5-aminosalicylate in patients with Inflammatory Bowel Disease under anti-TNF therapy: A nationwide population-based study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P659: Efficacy of switching from infliximab to golimumab in ulcerative colitis patients on deep remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P659: FMT as a treatment for IBD: A national survey of gastroenterologists in the UK
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P659: No decrease in number of new Inflammatory Bowel Disease diagnoses in children in the Netherlands during the Covid-19 pandemic: a nationwide retrospective cohort study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P659: Therapeutic drug monitoring of anti-TNFα drugs in a UK tertiary IBD unit
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P660 Evaluating the effectiveness of disease assessment at 2 weeks following a course of oral steroids: Does early intervention affect outcomes?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P660: A pilot elastography study in patients with inflammatory bowel disease on long-term treatment with azathioprine
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P660: Body composition and health-related quality of life in adult Crohn's Disease during clinical remission: The INTICO2 cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P660: Knowledge, attitudes, and awareness of contraceptive choices in women with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P660: Prevalence and clinical course of cytomegalovirus colitis in Asian patients with acute exacerbation of ulcerative colitis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P660: Stability of serum concentrations of infliximab and adalimumab across pregnancy in IBD
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P660: The impact of COVID-19 on the provision of care for patients with Inflammatory Bowel Disease: A cross sectional survey
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P661 Post-operative prophylaxis with anti-TNF in patients with Crohn’s disease who are anti-TNF experienced is associated with higher rates of prophylaxis failure
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P661: Clinical response over 24 weeks for initial and delayed responders to induction therapy with risankizumab in Crohn's disease: data from the ADVANCE and MOTIVATE studies
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P661: Comparable clinical efficacy, safety and immunogenicity of infliximab biosimilar (CT-P13) after transition from reference infliximab (Remicade®) in children with established inflammatory bowel disease: a multi-centre prospective observational study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P661: Early histological improvement demonstrated with oral ozanimod in patients with moderately to severely active Crohn’s disease in the STEPSTONE trial
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P661: Pre-diagnostic vitamin D levels in Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P661: Radon exposure and inflammatory bowel disease in a radon prone area
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM